Brief: Prothena Announces Achievement Of $40 Mln Clinical Milestone Payment From Novo Nordisk For Prx004/Nnc6019
21/11/2022 23:29
Nov 21 (Reuters) - Prothena Corporation PLC PRTA.O :
* PROTHENA ANNOUNCES ACHIEVEMENT OF $40 MILLION CLINICAL
MILESTONE
PAYMENT FROM NOVO NORDISK FOR PRX004/NNC6019 UNDER INVESTIGATION
FOR THE TREATMENT OF ATTR CARDIOMYOPATHY
Source: (shorturl.at/MSUY2)
Further company coverage: PRTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prothena
See all newsProthena Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Biotech firm Prothena's Q2 net loss narrows on lower expenses
Brief: Prothena Q2 Net Income USD -18.583 Million
Prothena Corporation PLC expected to post a loss of 39 cents a share - Earnings Preview
Prothena posts Q1 revenue surge fueled by $50 million Novo Nordisk milestone payment